I wanted to get back into INO large after the start of the year around $2.00, but it appears that maybe the ship has already set sail....maybe it'll still double from $2.50ish heading into VGX-3100 phase II results?
My guess is that we're at or very close to the bottom in gold. (Everybody is bearish, which usually occurs at the bottom).
On another note, this is crazy time in biotech!! The momentum players are running amuck. Last week it was ARIA. This week it's INO. I'm hoping next it will be IDRA (started today?) or CYTR (again?) or MACK. The key is to spot the early signs, such as massive volume spike.